Patent details

Basic Information

Publication number:

EP2377519

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP111739629

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Pharmaceutical Composition Comprising Octreotide Microparticles

French Title of Invention:

Composition pharmaceutique comprenant des microparticules d'octreotide

German Title of Invention:

Arzneimittel enthaltend Octreotidmikropartikel

SPC Number:

Dates

Filing date:

18/11/2003

Grant date:

23/03/2016

EP Publication Date:

23/03/2016

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

19/10/2011

EP B1 Publication Date:

23/03/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

18/11/2016

Expiration date:

18/11/2023

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

18/11/2003

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Name:

Novartis Pharma GmbH

Address:

Brunner Strasse 59, 1230 Wien, Austria (AT)

Inventor

1

Name:

Lambert Oliver

Address:

France (FR)

2

Name:

Petersen Holger

Address:

Germany (DE)

3

Name:

Bonny Jean-Daniel

Address:

Switzerland (CH)

4

Name:

Loeffler Rolf

Address:

Germany (DE)

5

Name:

Ausborn Michael

Address:

Germany (DE)

Priority

1

Priority Number:

0226993

Priority Date:

19/11/2002

Priority Country:

United Kingdom (GB)

2

Priority Number:

0227883

Priority Date:

29/11/2002

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

A61K 9/00;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages